SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description

   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back


Speaker
Oren Mason, MD

Speaker Affiliation
Oren Mason, MD
Attention MD
Assistant Professor
Michigan State University
College of Human Medicine
Grand Rapids, MI

email: info@adhdinadults.com
Title
: ADHD in Adults: Making the Diagnosis and Optimizing Treatment
Activity/Course #:
: NCMEDP111
Cost:
: Free
Release/Start Date:
: Jan 02 2014
Expiration Date:
: Dec 31 2017
Topics:
: Psychiatry
Target Audience:
: Primary Care Providers
Format:
: ADHD Dissemination Webcast
Estimated Time To Complete CME Activity:
: 1.0 Hours
Credit(s):
: 1.0 AMA PRA Category I Credit(s)
Hardware/Software Requirements:
(Chrome not supported at this time)

Inattention, hyperactivity, and impulsivity are the core symptoms of ADHD, a neuropsychiatric disorder that affects children, adolescents, and adults. Until the 1970s, however, ADHD was believed to be a childhood disorder that was outgrown by adulthood.

In the area of diagnosing and treating ADHD in adults, primary care physicians need to have a better understanding of the etiology of ADHD, subtypes of ADHD that can be present in adults, characteristics of different ADHD subtypes, and appropriate assessment tools to collect meaningful data (interview protocols, rating scales, symptom checklists, etc) for the evaluation of ADHD and co-morbid psychiatric conditions.

Welcome to the National Association for Continuing Education webcast from the NACE Emerging Challenges in Primary Care Update: 2012 conference. The topic of this webcast is ADHD in Adults: Making the Diagnosis and Optimizing Treatment.

The program was captured live in Denver, Colorado on June 16, 2012 and features Dr. Oren Mason. Dr. Mason is in private practice, Attention MD, in Grand Rapids, MI and he is an Assistant Professor at Michigan State University College of Human Medicine in Grand Rapids, MI.

Learning Objectives
After completing this activity, the reader should be better able to:

  1. Describe existing guidelines and best practices in the diagnosis and treatment of ADHD in adults
  2. Identify risks for co-morbidities in adult patients with ADHD with emphasis on anxiety disorders, mood disorders, and substance use/abuse disorders
  3. Plan a pharmacologic treatment program for adults diagnosed with simple ADHD and more complex ADHD that is complicated by co-morbidities
  4. Identify psychosocial treatments for adults diagnosed with ADHD
This webcast was recorded live and is being used with the permission of the presenter.

How To Obtain Your CME Certificate
Register for the course at www.naceonline.com.
  1. View the content.
  2. Complete and submit the post-test and evaluation.
  3. A minimum passing score of 60% must be earned on the post-test in order to complete the CME
    activity.
  4. Print your CME certificate.

Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure is provided below.

Oren Mason, MD, Speaker, has the following relationships to disclose: Speakers Bureau: Lilly, Shire, and Shionogi; Advising/Consulting: Lilly.

Anthony Rostain, MD, MA, Activity Planning Committee, has the following relationships to disclose: Advisory Board: Shire and Ortho-McNeill-Janssen.

Harvey C. Parker, Ph.D., Speaker and Activity Planning Committee, has the following relationships to disclose: co-owner of Specialty Press, Inc. and Health Link Systems, Inc.

Lenard Adler, MD, Activity Planning Committee, has the following relationships to disclose: Grant/Research Support: Bristol-Myers Squibb, Pfizer, Shire, Eli Lilly, Ortho McNeil/Jannsen/Johnson and Johnson and the National Institute of Drug Abuse; Advisory Board and Consultant: Eli Lilly, Major League Baseball, Mindsite, Organon, Ortho McNeil/Jannsen/Johnson and Johnson, Shire, i3 Research and Epi-Q, INC; Research: AstraZeneca Pharmaceuticals Consultant—Otsuka Pharmaceuticals.

Russell A. Barkley, Ph.D., Activity Planning Committee, has the following relationships to disclose: Speaker/Consultant: Eli Lilly, Shire, McNeil, Janssen-Orth, Janssen-Cilag and Novartis.

Kevin Murphy, Ph.D., Activity Planning Committee, has the following relationship to disclose: Speaker’s Bureau: Shire.

Russell Ramsay, Ph.D., Activity Planning Committee, has no relationships to disclose.

Gregg Sherman, MD, Course Director, has no relationships to disclose.

Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.

Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.
Commercial Support
This activity was originally supported by an independent medical educational grant from Shire.

Continued support was provided by independent medical educational grant from Shire; and an educational grant from Arbor Pharmaceuticals.